Fideuram Intesa Sanpaolo Private Banking S.P.A. Acquires Shares of 88,086 Xylem Inc. $XYL

Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new stake in Xylem Inc. (NYSE:XYL) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 88,086 shares of the industrial products company’s stock, valued at approximately $11,996,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Knuff & Co LLC purchased a new stake in Xylem in the third quarter valued at approximately $27,000. Board of the Pension Protection Fund purchased a new stake in Xylem in the fourth quarter valued at approximately $27,000. Wexford Capital LP purchased a new stake in Xylem in the third quarter valued at approximately $27,000. Ramirez Asset Management Inc. lifted its stake in Xylem by 100.0% in the third quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock valued at $30,000 after buying an additional 100 shares during the last quarter. Finally, Grey Fox Wealth Advisors LLC purchased a new stake in Xylem in the third quarter valued at approximately $34,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Trading Down 1.8%

Shares of XYL stock opened at $106.32 on Wednesday. The business’s fifty day moving average price is $119.71 and its 200 day moving average price is $131.91. Xylem Inc. has a 1-year low of $106.19 and a 1-year high of $154.27. The firm has a market capitalization of $25.27 billion, a PE ratio of 26.45, a P/E/G ratio of 1.54 and a beta of 1.08. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The firm had revenue of $2.13 billion for the quarter, compared to analyst estimates of $2.11 billion. During the same quarter in the prior year, the company posted $1.03 earnings per share. Xylem’s quarterly revenue was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, sell-side analysts forecast that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Thursday, May 28th will be issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date of this dividend is Thursday, May 28th. Xylem’s dividend payout ratio is currently 42.79%.

Xylem announced that its board has approved a share buyback program on Wednesday, February 25th that permits the company to buyback $1.50 billion in outstanding shares. This buyback authorization permits the industrial products company to purchase up to 4.8% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on XYL shares. JPMorgan Chase & Co. reduced their price objective on Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. Citigroup dropped their target price on Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Barclays dropped their target price on Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a report on Wednesday, April 29th. Robert W. Baird set a $161.00 target price on Xylem in a report on Wednesday, February 11th. Finally, Mizuho set a $138.00 target price on Xylem in a report on Wednesday, February 11th. Seven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $152.77.

Insiders Place Their Bets

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the transaction, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. This represents a 54.22% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Jerome A. Peribere acquired 1,210 shares of the company’s stock in a transaction that occurred on Monday, May 4th. The shares were acquired at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the acquisition, the director directly owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.32% of the company’s stock.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.